SlideShare uma empresa Scribd logo
1 de 20
Endometrial Hyperplasia S.Laxiny, Medical Student, FHCS, EUSL.
Endometrial Hyperplasia Endometrial hyperplasia is a condition of excessive proliferation of the cells of the endometrium-Endometrial glands & surrounding tissue(Stroma). Endometrial hyperplasia is a non-cancerous condition. May involve part or all of the endometrium.
Pathogenesis Hyperplasia usually develops in the presence of continuous estrogen  stimulation  unopposed  by  progesterone. The female hormones—estrogen and progesterone—control the changes in the uterine lining.  Estrogen builds up the uterine lining.  Progesterone maintains and controls this growth.  Estrogen without enough progesterone may cause the lining of the uterus to thicken.
Risks for developing Endometrial Hyperplasia  Estrogen replacement therapy -Take estrogen without progesterone to replace the estrogen their body is no longer making and to relieve symptoms of menopause Polycystic ovary syndrome- women are anovulatory and have unopposed estrogen effect.  Estrogen producing tumours(e.g. granulosa cell tumour). Irregular Menstrul Periods-Skipmenstrual periods or have no periods at all –continuous unopposed estrogen activity. Perimenopause  period Overweight  Diabetes Mellitus
Classification of endometrial hyperplasia Simple hyperplasia (cystic without atypia)  Complex hyperplasia (adenomatous without atypia) Atypical simple hyperplasia (cystic with atypia) Atypical complex  hyperplasia (adenomatous with atypia)
Simple Endometrial Hyperlasia Simple or Cystic Hyperplasia Proliferation of glands and stroma. Glands vary in size, some are cystic. The epithelial cells are active with stratification and mitoses
Complex Endometrial Hyperlasia a very complex gland pattern abnormally shaped  glands, in- and out-pouching. Glands are crowded with very little endometrial stroma,
AtypicalEndometrial Hyperplasia  Increased gland density Nuclear atypia - hyperchromatic,  enlarged epithelial cells with an increased nuclear to cytoplasmic ratio.  Resembles well differentiated carcinoma.
Atypical Endometrial Hyperplasia On high power view the nuclear atypia can be seen: Nuclei are of variable size, shape and chromatin distribution; prominent nucleoli.
Symptoms of Endometrial Hyperplasia Vaginal discharge Abdominal pain Bleeding between menstrual periods Heavy or prolonged menstrual periods
Progressionof Endometrial Hyperplasia Hyperplasia without atypia rarely progresses to endometrial cancer,  Hyperplasia with atypia is a precancerous condition that may progress to overt malignancy.
Investigations ,[object Object]
Endometrial biopsy
Dilation and curettage (D&C)
Hysteroscopy,[object Object]
Focal Simple Hyperplasia
Atypical Hyperplasia
Treatment  In most cases, endometrial hyperplasia can be treated with medication that is a form of the hormone progesterone.  Taking progesterone will cause the lining to shed and prevent it from building up again. It often will cause vaginal bleeding.   Treatment for endometrial hyperplasia  without Atypia In hyperplasia without atypia, cyclical progestin therapy is the recommended choice in women not seeking  contraception. 10 mg medroxyprogesterone acetate for  10 to 14 days a month for  3 to 6 months. If they have a normal biopsy and are asymptomatic, discontinue therapy. If the hyperplasia is persistent, then continuous-dose progestin therapy is instituted with 20 mg/day for 3 to 6 months In women desiring contraception, OCP can be  used or an injectable depot preparation of medroxyprogesterone acetate ( Depo-Provera ) can be administered in the normal dose used for contraception - 150 mg every 12 weeks.
Commonly Used Progesterone- Only Agents       Generic Name	  Common Trade Names     Common Dosage Progesterone                 Crinone;Progestasert;  Prometrium                                      200 mg PO MedroxyprogesteroneProvera                                           10-20 mg PO        Acetate                           Depo-Provera                                 150 mg IM Megestrol acetate	    Megace 	                         40-320 mg PO LevonorgestrelMirena IUS 	    1 intrauterine every 5 years
Treatment for Atypical  endometrial hyperplasia Ideal management is hysterectomy If hysterectomy is not a viable option for young patient & patient is a very poor surgical candidate),  high-dose continuous progestin therapy can be used. Typically, 20 mg of medroxyprogesterone acetate daily.  Another option is 40 to 160 mg megestrol acetate daily for 6 months.  biopsies every 6 months because of the high risk of recurrence.

Mais conteúdo relacionado

Mais procurados

Pre cancerous lesions of cervix.pptx
Pre cancerous lesions of cervix.pptxPre cancerous lesions of cervix.pptx
Pre cancerous lesions of cervix.pptx
Gitanjali Kumari
 
Vaginal Cancer
Vaginal CancerVaginal Cancer
Vaginal Cancer
fitango
 

Mais procurados (20)

Post menopausal bleeding
Post menopausal bleedingPost menopausal bleeding
Post menopausal bleeding
 
Pre cancerous lesions of cervix.pptx
Pre cancerous lesions of cervix.pptxPre cancerous lesions of cervix.pptx
Pre cancerous lesions of cervix.pptx
 
Adenomyosis
AdenomyosisAdenomyosis
Adenomyosis
 
Genital tuberculosis
Genital tuberculosisGenital tuberculosis
Genital tuberculosis
 
Urinary Tract Fistulas -(VVF) Etiology, Diagnosis, Management
Urinary Tract Fistulas -(VVF) Etiology, Diagnosis, ManagementUrinary Tract Fistulas -(VVF) Etiology, Diagnosis, Management
Urinary Tract Fistulas -(VVF) Etiology, Diagnosis, Management
 
Benign Cervical Lesions
Benign Cervical LesionsBenign Cervical Lesions
Benign Cervical Lesions
 
Adenomyosis
AdenomyosisAdenomyosis
Adenomyosis
 
Post menopausal bleeding seminar
Post menopausal bleeding seminarPost menopausal bleeding seminar
Post menopausal bleeding seminar
 
Vaginal Cancer
Vaginal CancerVaginal Cancer
Vaginal Cancer
 
Diseases of vulva
Diseases of vulvaDiseases of vulva
Diseases of vulva
 
Postmenopausal bleeding for undergraduate
Postmenopausal bleeding for undergraduatePostmenopausal bleeding for undergraduate
Postmenopausal bleeding for undergraduate
 
Ovarian torsion
Ovarian torsionOvarian torsion
Ovarian torsion
 
Gestational trophoblastic diseases
Gestational trophoblastic diseasesGestational trophoblastic diseases
Gestational trophoblastic diseases
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
 
Classification of ovarian tumors
Classification of ovarian tumorsClassification of ovarian tumors
Classification of ovarian tumors
 
Mastalgia
MastalgiaMastalgia
Mastalgia
 
Preterm Premature Rupture Of Membranes (PPROM)
Preterm Premature Rupture Of Membranes (PPROM)Preterm Premature Rupture Of Membranes (PPROM)
Preterm Premature Rupture Of Membranes (PPROM)
 
OVARIAN TUMOURS
OVARIAN TUMOURSOVARIAN TUMOURS
OVARIAN TUMOURS
 
Pelvic mass
Pelvic massPelvic mass
Pelvic mass
 
Post Menopausal Bleeding
Post Menopausal BleedingPost Menopausal Bleeding
Post Menopausal Bleeding
 

Semelhante a Endometrial hyperplasia.ppt

Estrogen ,progestrone & oral contreceptive
Estrogen ,progestrone & oral contreceptiveEstrogen ,progestrone & oral contreceptive
Estrogen ,progestrone & oral contreceptive
KATHIR B.PHARM
 
Management of endometrial hyperplasia
Management of endometrial hyperplasiaManagement of endometrial hyperplasia
Management of endometrial hyperplasia
Ahmad Saber
 
endometriosis - a 21st century enigma
endometriosis - a 21st century enigmaendometriosis - a 21st century enigma
endometriosis - a 21st century enigma
parul sehgal
 
dysfunctional uterine bleeding
dysfunctional uterine bleedingdysfunctional uterine bleeding
dysfunctional uterine bleeding
Karl Daniel, M.D.
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptx
ashharnomani
 
24.复件 Family Panning2008
24.复件 Family Panning200824.复件 Family Panning2008
24.复件 Family Panning2008
Deep Deep
 
endo.pptx
endo.pptxendo.pptx
endo.pptx
yashikasingh37
 

Semelhante a Endometrial hyperplasia.ppt (20)

Premalignant lesions of the endometrium
Premalignant lesions of the endometriumPremalignant lesions of the endometrium
Premalignant lesions of the endometrium
 
Estrogen ,progestrone & oral contreceptive
Estrogen ,progestrone & oral contreceptiveEstrogen ,progestrone & oral contreceptive
Estrogen ,progestrone & oral contreceptive
 
Management of endometrial hyperplasia
Management of endometrial hyperplasiaManagement of endometrial hyperplasia
Management of endometrial hyperplasia
 
contraception.pptx
contraception.pptxcontraception.pptx
contraception.pptx
 
Hormonal Replacement Therapy
Hormonal Replacement TherapyHormonal Replacement Therapy
Hormonal Replacement Therapy
 
endometriosis - a 21st century enigma
endometriosis - a 21st century enigmaendometriosis - a 21st century enigma
endometriosis - a 21st century enigma
 
dysfunctional uterine bleeding
dysfunctional uterine bleedingdysfunctional uterine bleeding
dysfunctional uterine bleeding
 
Hormonal contraceptives satya ppt
Hormonal contraceptives satya pptHormonal contraceptives satya ppt
Hormonal contraceptives satya ppt
 
Gynecomastia
GynecomastiaGynecomastia
Gynecomastia
 
Gynecomastia by Dr Shahjada Selim
Gynecomastia by Dr Shahjada SelimGynecomastia by Dr Shahjada Selim
Gynecomastia by Dr Shahjada Selim
 
Abnormal Uterine Bleeding.pptx
Abnormal Uterine Bleeding.pptxAbnormal Uterine Bleeding.pptx
Abnormal Uterine Bleeding.pptx
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptx
 
24.复件 Family Panning2008
24.复件 Family Panning200824.复件 Family Panning2008
24.复件 Family Panning2008
 
Dysfunctional uterine bleeding
Dysfunctional uterine bleedingDysfunctional uterine bleeding
Dysfunctional uterine bleeding
 
presentation of gynecomastia MSN-I sam (3).pptx
presentation of gynecomastia MSN-I sam (3).pptxpresentation of gynecomastia MSN-I sam (3).pptx
presentation of gynecomastia MSN-I sam (3).pptx
 
endo.pptx
endo.pptxendo.pptx
endo.pptx
 
PROGESTRONE.pptx
PROGESTRONE.pptxPROGESTRONE.pptx
PROGESTRONE.pptx
 
Drm science lecture 2 CONTRACEPTIVES AND IUDs
Drm science lecture 2 CONTRACEPTIVES AND IUDsDrm science lecture 2 CONTRACEPTIVES AND IUDs
Drm science lecture 2 CONTRACEPTIVES AND IUDs
 
Gynecomastia by Dr Shahjada Selim
Gynecomastia by Dr Shahjada SelimGynecomastia by Dr Shahjada Selim
Gynecomastia by Dr Shahjada Selim
 
Presentation1
Presentation1Presentation1
Presentation1
 

Endometrial hyperplasia.ppt

  • 1. Endometrial Hyperplasia S.Laxiny, Medical Student, FHCS, EUSL.
  • 2. Endometrial Hyperplasia Endometrial hyperplasia is a condition of excessive proliferation of the cells of the endometrium-Endometrial glands & surrounding tissue(Stroma). Endometrial hyperplasia is a non-cancerous condition. May involve part or all of the endometrium.
  • 3. Pathogenesis Hyperplasia usually develops in the presence of continuous estrogen stimulation unopposed by progesterone. The female hormones—estrogen and progesterone—control the changes in the uterine lining. Estrogen builds up the uterine lining. Progesterone maintains and controls this growth. Estrogen without enough progesterone may cause the lining of the uterus to thicken.
  • 4. Risks for developing Endometrial Hyperplasia Estrogen replacement therapy -Take estrogen without progesterone to replace the estrogen their body is no longer making and to relieve symptoms of menopause Polycystic ovary syndrome- women are anovulatory and have unopposed estrogen effect. Estrogen producing tumours(e.g. granulosa cell tumour). Irregular Menstrul Periods-Skipmenstrual periods or have no periods at all –continuous unopposed estrogen activity. Perimenopause period Overweight Diabetes Mellitus
  • 5. Classification of endometrial hyperplasia Simple hyperplasia (cystic without atypia) Complex hyperplasia (adenomatous without atypia) Atypical simple hyperplasia (cystic with atypia) Atypical complex hyperplasia (adenomatous with atypia)
  • 6. Simple Endometrial Hyperlasia Simple or Cystic Hyperplasia Proliferation of glands and stroma. Glands vary in size, some are cystic. The epithelial cells are active with stratification and mitoses
  • 7. Complex Endometrial Hyperlasia a very complex gland pattern abnormally shaped glands, in- and out-pouching. Glands are crowded with very little endometrial stroma,
  • 8. AtypicalEndometrial Hyperplasia Increased gland density Nuclear atypia - hyperchromatic, enlarged epithelial cells with an increased nuclear to cytoplasmic ratio. Resembles well differentiated carcinoma.
  • 9. Atypical Endometrial Hyperplasia On high power view the nuclear atypia can be seen: Nuclei are of variable size, shape and chromatin distribution; prominent nucleoli.
  • 10. Symptoms of Endometrial Hyperplasia Vaginal discharge Abdominal pain Bleeding between menstrual periods Heavy or prolonged menstrual periods
  • 11. Progressionof Endometrial Hyperplasia Hyperplasia without atypia rarely progresses to endometrial cancer, Hyperplasia with atypia is a precancerous condition that may progress to overt malignancy.
  • 12.
  • 15.
  • 18. Treatment In most cases, endometrial hyperplasia can be treated with medication that is a form of the hormone progesterone. Taking progesterone will cause the lining to shed and prevent it from building up again. It often will cause vaginal bleeding. Treatment for endometrial hyperplasia without Atypia In hyperplasia without atypia, cyclical progestin therapy is the recommended choice in women not seeking contraception. 10 mg medroxyprogesterone acetate for 10 to 14 days a month for 3 to 6 months. If they have a normal biopsy and are asymptomatic, discontinue therapy. If the hyperplasia is persistent, then continuous-dose progestin therapy is instituted with 20 mg/day for 3 to 6 months In women desiring contraception, OCP can be used or an injectable depot preparation of medroxyprogesterone acetate ( Depo-Provera ) can be administered in the normal dose used for contraception - 150 mg every 12 weeks.
  • 19. Commonly Used Progesterone- Only Agents Generic Name Common Trade Names Common Dosage Progesterone Crinone;Progestasert; Prometrium 200 mg PO MedroxyprogesteroneProvera 10-20 mg PO Acetate Depo-Provera 150 mg IM Megestrol acetate Megace 40-320 mg PO LevonorgestrelMirena IUS 1 intrauterine every 5 years
  • 20. Treatment for Atypical endometrial hyperplasia Ideal management is hysterectomy If hysterectomy is not a viable option for young patient & patient is a very poor surgical candidate), high-dose continuous progestin therapy can be used. Typically, 20 mg of medroxyprogesterone acetate daily. Another option is 40 to 160 mg megestrol acetate daily for 6 months. biopsies every 6 months because of the high risk of recurrence.
  • 21. Protecting Against EndometrialHyperplasia Take estrogen with progesterone after menopause, Women who don't have regular periods-Take oral contraceptives contain estrogen along with a form of progesterone. If you are overweight, losing weight may help.
  • 22. Thank You